Cost-effectiveness
The incremental benefit of PW-PAD versus control group was 0.045 QALY (95% CI, 0.040 to 0.046); the incremental cost was −€4,286 (95% CI, −4,711 to −4,020) (The bootstrap distribution of the ICER showed that 100% of the 5,000 replicates of ICER were located in the lower-right quadrant of the scatterplot plan (Cost-effectiveness plane associated with the 12-month cost per QALY analysis.The graph contains axes that represent the incremental cost (The willingness to pay (WTP), or ICER threshold, is used as the slope of a line intersecting the origin of the plot. The WTP line in the graph intersects points having the specified ICER value, and the region below and to the right of the line includes points where the intervention/PW-PAD is more cost-effective than the usual care/control. The ellipsis shows the 95% CI.